BMN
Blackrock 2037 Municipal Target Term Trust
Set alert
- YTD
- -12.26%
- 1 year
- -7.12%
- Open
- 22.78
- Prev close
- 22.98
- Mkt cap
- 141.21M
- Vol
- 60.69K
- Avg vol
- 26.89K
- EPS
- 2.21
- P/E
- 10.39
- Div yield
- 5.07%
More statistics
- Low
- 22.75
- High
- 23.08
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.19
- Inst. own
- 5.62%
- Dividend
- 1.12
- Ex-div date
- Dec 13, 2023
- 50-d avg
- 25.20
- 200-d avg
- 24.75
- 1y target
- 0.00
News
1 week ago seekingalpha.com
Income-Covered Closed-End Fund Report, October 2026
Our Income-Covered screen looks for closed-end funds whose net investment income fully covers the distribution (coverage above 100%) while trading at a discount to NAV, using data as of the close of…
1 month ago defenseworld.net
Blackrock 2037 Municipal Target Term Trust (NYSE:BMN) Sees Significant Drop in Short Interest
Blackrock 2037 Municipal Target Term Trust (NYSE: BMN - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short…
2 months ago defenseworld.net
Blackrock 2037 Municipal Target Term Trust (NYSE:BMN) Shares Up 0.9% – Here’s What Happened
Blackrock 2037 Municipal Target Term Trust (NYSE: BMN - Get Free Report)'s stock price traded up 0.9% during trading on Monday. The stock traded as high as $25.60 and last traded at $25.3650. 20,147…
4 months ago prnewswire.com
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026
Data from an investigator-led study showed treatment with VOXZOGO resulted in sustained improvements in growth over three years in children with hypochondroplasia New Phase 1 results also presented…
5 months ago prnewswire.com
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency
ENERGY 3 study met 1 of 2 co-primary endpoints in children with ENPP1 deficiency Treatment with BMN 401 led to statistically significant increases in plasma inorganic pyrophosphate (PPi)…
6 months ago cnbc.com
Bitcoin surged in April, but weak buyer demand makes the rally vulnerable
Bitcoin gained 12.7% in April, registering back-to-back monthly gains and its best month since April 2025. The run was driven by leveraged trading activity in the derivatives market while demand for…
6 months ago defenseworld.net
Blackrock 2037 Municipal Target Term Trust (NYSE:BMN) Short Interest Update
Blackrock 2037 Municipal Target Term Trust (NYSE: BMN - Get Free Report) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totaling 15,760 shares, a…
7 months ago seekingalpha.com
Income-Covered Closed-End Fund Report, March 2026
The Income-Covered Closed-End Fund Report screens for CEFs with distribution coverage exceeding 100%, targeting funds less likely to cut payouts. Discounted, fully-covered CEFs offer dual benefits:…
8 months ago seekingalpha.com
Closed-End Funds: Screening For The Best Municipal Bond Exposure
Municipal bond closed-end funds (CEFs) are seeing narrowing discounts, with NXP and MHF offering the most compelling value in the space at present. Leverage costs are easing as the Fed cuts rates,…
1 year ago businesswire.com
BlackRock 2037 Municipal Target Term Trust (BMN) Announces Variable Rate Preferred Share Issuance
NEW YORK--(BUSINESS WIRE)---- $BMN--BlackRock Advisors, LLC (“BlackRock”) announced today that BlackRock 2037 Municipal Target Term Trust (NYSE: BMN; CUSIP: 09262G108) (the “Fund”) successfully…
1 year ago seekingalpha.com
BioMarin: Acquisition Of Inozyme Brings Forth Late-Stage ERT BMN 401
BioMarin's revenue growth is strong, with Q2 2025 revenues up 16% year-over-year and full-year guidance raised to $3.125–$3.2 billion. The Inozyme acquisition brings late-stage BMN 401 for ENPP1…
1 year ago benzinga.com
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
On Tuesday, Biomarin Pharmaceutical Inc. BMRN reported second-quarter adjusted earnings of $1.44, up 50% year over year, beating the consensus of 85 cents and sales of $825.41 million, up 16%,…
1 year ago prnewswire.com
BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS
Second Quarter 2025 Total Revenues of $825 million (+16% Y/Y and +17% at Constant Currency Y/Y) Second Quarter 2025 GAAP Diluted Earnings Per Share (EPS) of $1.23 (+124% Y/Y) Second Quarter 2025…
2 years ago seekingalpha.com
BMN: Tax-Free Income With Capacity To Leverage Up
BlackRock 2037 Municipal Target Term Trust offers primarily tax-free income through a diversified muni bond portfolio. BMN's modest leverage with the Fed cutting rates puts the fund in a unique…
2 years ago seekingalpha.com
BMN: Attractive Discount And Starting To Employ Leverage
BlackRock 2037 Municipal Target Term Trust (BMN) launched at a favorable time, avoiding the municipal bond market slide caused by rising rates. BMN is a target term fund that aims to return its NAV…
2 years ago seekingalpha.com
Municipal CEF Sector Update: What We're Doing After A Roller Coaster Ride
Municipal CEF Sector Update: What We're Doing After A Roller Coaster Ride
2 years ago businesswire.com
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: Declaration- 3/1/2024 Ex-Date- 3/14/2024 Record-…
2 years ago seekingalpha.com
Key Decision Factors For CEF Allocation In Today's Market
Key Decision Factors For CEF Allocation In Today's Market
2 years ago seekingalpha.com
BMN: A Defensive 5% Yielding Muni CEF
BlackRock 2037 Municipal Target Term Trust is a target term fund with the objective of returning $25 at its termination date in 2037. The BMN closed-end fund is a defensive Muni CEF option owing to…
2 years ago seekingalpha.com
The Dirty Dozen CEFs From 2021: A Summary
In 2021, a dozen closed-end funds, or CEFs, were launched, but none of them performed well, with all of them experiencing negative total returns since inception. The CEFs trade at wide discounts to…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 386 stocks made new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During the session on Thursday, 461 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 150 companies set new 52-week lows.